Skip to content

Fingolimod

Also known as Gilenya (us), Fingimod (india)

Autoimmune & Inflammation
Save $3,090/mo
53× cheaper

A once-daily oral therapy for relapsing multiple sclerosis.

United States
$3,150
per month
India
$60
per month
You save
$3,090
98% cheaper in India
31.1K US scripts/yr$96.2M potential annual savings$98M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC19H33NO2

SMILES: CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N

Compare the price
US price$3,150per month
India price$60per month
You save$3,09098% less

Based on 30 capsules per month. US $105.00 vs India $2.00 per capsule.

Total over 1 periodSave $3,090$3,150$60
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$18,540
Estimated travel cost
− $2,300
Net savings after travel
$16,240

Even after travel, you could come out ahead by about $16,240.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Fingolimod is filled about 31.1K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$98M
If sourced from India
$1.9M
Potential annual savings
$96.2M
98%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.